Home › Funds › Slocum, Gordon & Co LLP › MRNA

Slocum, Gordon & Co LLP position in MRNA

MODERNA INC · Health Care

Slocum, Gordon & Co LLP reported holding 3,000 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$578K, representing 0.40% of its reported portfolio and ranking #43 among its reported holdings. Slocum, Gordon & Co LLP has disclosed MRNA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)3.00K sh
Reported value held$577.71K
Portfolio Weight0.40%
First reportedQ2 2026
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Slocum, Gordon & Co LLP's MRNA position evolved

Slocum, Gordon & Co LLP first disclosed a stake in MRNA in Q2 2026 at 3,000 shares (US$210K). The position peaked in Q3 2026 at 3,000 shares, worth US$578K. Across 2 filings, Slocum, Gordon & Co LLP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,000 shares valued at US$578K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 3.00K $210.09K New
Q3 2026 3.00K $577.71K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Slocum, Gordon & Co LLP held MRNA?

Slocum, Gordon & Co LLP has disclosed MRNA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Slocum, Gordon & Co LLP's current position in MRNA?

As of Q3 2026, Slocum, Gordon & Co LLP holds 3.00K shares of MRNA (MODERNA INC), valued at $577.71K, representing 0.40% of its reported portfolio and ranking #43.

Has Slocum, Gordon & Co LLP been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Slocum, Gordon & Co LLP held unchanged its position in MRNA. The position peaked in Q3 2026 at 3.00K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.